Search filters

List of works by Klaus Beiske

Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation

scientific article published on 19 October 2008

Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma

article

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling

scientific article

Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency

scientific article

Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.

scientific article

Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

scientific article published on 18 August 2010

Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies

scientific article published on 04 April 2007

Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study

scientific article published on 25 March 2020

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

article

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

scientific article

Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain

scientific article published on 25 February 2019

T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling

scientific article published on 7 December 2017

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

scientific article published on 18 January 2019

The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.

scientific article published on 24 June 2016

Paulina is supported by:

About Paulina

Help